Toxic epidermal necrolysis after mifepristone/gemeprost-induced abortion.
Lecorvaisier-Pieto
C
C
Dermatology Clinic, Hôpital Charles Nicolle, Rouen, France.
Joly
P
P
Thomine
E
E
Tanasescu
S
S
Noblet
C
C
Lauret
P
P
D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000021:Abortifacient Agents, Steroidal / Q000009:adverse effects*; D000028:Abortion, Induced; D000328:Adult; D000527:Alprostadil / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006727:Hormone Antagonists / Q000009:adverse effects; D006801:Humans; D015735:Mifepristone / Q000009:adverse effects*; D011247:Pregnancy; D011459:Prostaglandins E, Synthetic / Q000009:adverse effects; D013262:Stevens-Johnson Syndrome / Q000209:etiology*
D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D006727:Hormone Antagonists; D011459:Prostaglandins E, Synthetic; D015735:Mifepristone; C021182:gemeprost; D000527:Alprostadil